ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Clinical trials for ANTHRACYCLINE-INDUCED CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE-INDUCED CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE-INDUCED CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial aims to shield cancer Patients' hearts from chemo side effects
Prevention Not yet recruitingThis study tests whether the drug sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 participants will receive either the drug or a placebo during their first round of c…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated May 26, 2026 05:55 UTC
-
Heart shield: statin may prevent Chemo-Induced cardiac damage in breast cancer
Prevention Not yet recruitingThis study tests whether rosuvastatin, a cholesterol-lowering drug, can prevent heart damage in women with breast cancer receiving anthracycline chemotherapy. 400 participants will take either rosuvastatin or a placebo daily for 12 months. The goal is to see if the drug helps mai…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated May 22, 2026 13:50 UTC